Precision Medicine

U of California, Irvine to Launch Institute for Precision Health

by Erin McNemar, MPA

To address challenges such as health equity and the cost of care, the University of California, Irvine (UCI) announced the launch of the Institute for Precision Health (IPH). The institute will...

Ohio Cancer Center Joins Precision Oncology Alliance

by Erin McNemar, MPA

The Ohio State University Comprehensive Cancer Center –Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC - James) have joined Caris Life Science's Precision...

UNC Researchers To Lead NIH Precision Nutrition Centers

by Erin McNemar, MPA

 The University of North Carolina (UNC) at Chapel Hill will play an important role in the National Institutes of Health's (NIH) new study on precision nutrition. UNC received two of 14 awards...

Industry Applauds as Biden Reboots Cancer Moonshot

by Erin McNemar, MPA

Almost six years to the day after the Cancer Moonshot Task Force met for the first time, President Joe Biden announced the reignition of the initiative, aiming to reduce the cancer death rate by 50...

NIH Researchers Develop Personalized Breast Cancer Therapy Approach

by Erin McNemar, MPA

National Cancer Institute researchers have revealed an experimental form of immunotherapy that uses a patient’s tumor-fighting immune cells to treat those with metastatic breast cancer, advancing...

Blood Biomarkers Can Help Determine Post-Pregnancy Depression 

by Erin McNemar, MPA

Michigan-based researchers found that signs of inflammation in blood could predict and identify severe depression during and after pregnancy, promoting precision medicine efforts. By...

How Can Artificial Intelligence Change Medical Imaging?  

by Erin McNemar, MPA

Increasingly, researchers are looking for ways to implement artificial intelligence into medical imaging. There are several different cases for why a patient might need medical imaging. Whether it’s for a cardiac event, fracture,...

Using Machine Learning For Personalized Breast Cancer Screenings 

by Erin McNemar, MPA

Researchers from MIT’s Computer Science and Artificial Intelligence Laboratory (CSAIL) and Jameel Clinic for Machine Learning and Health studied the use of machine learning to...

Using Biomarkers to Prevent, Cure Neurological Disorders   

by Erin McNemar, MPA

To better understand why so many individuals worldwide suffer from brain diseases, Cleveland Clinic has launched a new study aiming to identify disease biomarkers early, preventing...

Gene Inhibiting Assists Chronic Disease Prevention, Targeted Therapy 

by Erin McNemar, MPA

According to researchers from Massachusetts General Hospital, an olfactory receptor gene that aids in the sense of smell could play a role in the metastasis of breast cancer to the brain. By inhibiting...

Machine Learning Helps Repair Genetic Damage

by Erin McNemar, MPA

Using machine learning techniques, researchers from Massachusetts General Hospital and the National Cancer Research Centre, have discovered how to repair genetic damage to prevent DNA...

Identifying Genetic Mutations Can Advance Precision Medicine Efforts

by Erin McNemar, MPA

By studying genetic mutations in patients with schizophrenia, researchers can identify disease-associated genetic variants, paving the way for precision medicine. The research was conducted...

Limiting Bias in Artificial Intelligence Tools, Personalized Medicine

by Erin McNemar, MPA

As more research looks to use medical data for artificial intelligence tools and personalized medicine, a new study shows how unintentional bias can impact design efforts. Additionally, the study...

How CVS Health Uses NCCN Guidelines to Advance Precision Medicine

by Erin McNemar, MPA

Organizations are constantly looking for ways to enhance treatment and patient experience. By incorporating National Comprehensive Cancer Network (NCCN) guidelines and precision medicine, CVS Health is working to improve cancer patient...

Artificial Intelligence, MRI Detect Early Signs Of Tumor Cell Death

by Erin McNemar, MPA

Massachusetts General Hospital (MGH) researchers found that magnetic resonance imaging (MRI) and artificial intelligence (AI) can be used to detect early signs of tumor cell death in response to a...

Top Opportunities for Artificial Intelligence to Improve Cancer Care

by Erin McNemar, MPA

As artificial intelligence (AI) continues to grow in the healthcare field, researchers are findings new ways to utilize its capabilities. In chronic disease management and prevention, especially in cancer research, AI has been critical in...

Population Health Disparities In Cancer Care Promotes Precision Medicine

by Erin McNemar, MPA

Mount Sinai researchers have found genetic differences between 14 tumor types in young adults compared to the same cancers in older adults. To address the population health disparities, researchers...

Triple-Negative Breast Cancer Biomarker A Potential Therapy Target

by Erin McNemar, MPA

Boston University School of Medicine researchers have discovered a metabolic enzyme and pathway in some triple-negative breast cancer (TNBC) patients. According to researchers, the hope is that their...

Predictive Model Determines Antidepressant Medication Response

by Erin McNemar, MPA

Using data from the National Institute of Mental Health, UT Southwestern Medical Center researchers created a predictive model to determine how a patient will respond to antidepressants. According to...

Using Genetic Data For Developing Personalized Cancer Therapies

by Erin McNemar, MPA

Indiana University researchers launched a new study to create personalized therapy for patients with triple-negative breast cancer based on genetic data. According to researchers, risk stratification...